Evidence map›Paper›PMID 35881232›Full record

ReviewProbiotics and antimicrobial proteins2022

Bacteriocin Production by Bacillus Species: Isolation, Characterization, and Application.

Victor Mercado, Jorge Olmos

Abstract readReview
PubMed Publisher
In one paragraph

Review in Probiotics and antimicrobial proteins, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 51 citations in OpenAlex.

  1. Pacin, a novel bacteriocin fromMicrobiology spectrum · 2026
    Article
  2. Review
  3. Genomic insights and evaluation ofFrontiers in cellular and infection microbiology · 2026
    Article
  4. First Report onAquaculture nutrition · 2026
    Article
  5. Protein Extraction fromJournal of microbiology and biotechnology · 2025
    Article
  6. Article
  7. Applied and environmental microbiology · 2025
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Two Antimicrobial Peptides Derived fromMolecules (Basel, Switzerland) · 2023
    Article
  16. Characterization of the Novel Leaderless Bacteriocin, Bawcin, fromInternational journal of molecular sciences · 2023
    Article
  17. The ProbioticMicroorganisms · 2023
    Article
  18. Pharmaceutics · 2023
    Review
  19. Characterization ofMicroorganisms · 2023
    Article
  20. Evaluation ofMicroorganisms · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Victor MercadoMolecular Microbiology Laboratory, Department of Marine Biotechnology, Centro de Investigación Científica Y de Educación Superior de Ensenada, 22860, Ensenada, Baja California, Mexico.ORCID 0000-0002-7748-4352
Jorge OlmosMolecular Microbiology Laboratory, Department of Marine Biotechnology, Centro de Investigación Científica Y de Educación Superior de Ensenada, 22860, Ensenada, Baja California, Mexico. jolmos@cicese.mx.ORCID 0000-0002-6797-5385
Centro de Investigación Científica y de Educación Superior de Ensenada · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotic resistance is a problem that has been increasing lately; therefore, it is important to find new alternatives to treat infections induced by pathogens that cannot be eliminated with available products. Small antimicrobial peptides (AMPs) known as bacteriocin could be an alternative to antibiotics because they have shown to be effective against a great number of multidrug-resistant microbes. In addition to its high specificity against microbial pathogens and its low cytotoxicity against human cells, most bacteriocin present tolerance to enzyme degradation and stability to temperature and pH alterations. Bacteriocins are small peptides with a great diversity of structures and functions; however, their mechanisms of action are still not well understood. In this review, bacteriocin produced by Bacillus species will be described, especially its mechanisms of action, culture conditions used to improve its production and state-of-the-art methodologies applied to identify them. Bacteriocin utilization as food preservatives and as new molecules to treat cancer also will be discussed.

Indexed as

BacillusBacteriocinsAnti-Bacterial AgentsHumansAnti-Bacterial AgentsBacteriocinsAMPBacillusBacteriocinCharacterizationPurification

Identifiers

PMID35881232
OpenAlexW4287877442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.